Alembic Pharmaceuticals Ltd

NSE: APLLTD · BSE: 533573 · Pharmaceuticals & Biotechnology · 14 announcements

Share price: ₹863.75
Market cap: ₹16,978 Cr
Revenue (annual): ₹7,345 Cr
Net profit (annual): ₹674.8 Cr
P/E (TTM): 24.5×Sector 50.4×
Promoter holding: 69.87%+0.13% QoQ
FII holding: 4.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Debt & Borrowing 2

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

25 Sep 2026 15:18 IST NSE

Debt & Borrowing

Alembic Pharmaceuticals Debt & Borrowing: ₹100 Cr

Alembic Pharmaceuticals Limited has redeemed Commercial Papers (CP) worth Rs. 100 Crores. The redemption was completed on the maturity date of September 25, 2026.

Value: ₹100.0 Cr

Read the filing ↗

23 Sep 2026 18:53 IST NSE

Debt & Borrowing

Alembic Pharmaceuticals Debt & Borrowing: ₹150 Cr

Alembic Pharmaceuticals has redeemed Commercial Papers worth Rs. 150 Crore upon maturity on 23rd September 2026.

Value: ₹150.0 Cr

Read the filing ↗